Ahmad, Maira J.
HRN: 26-24-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2024
CO-AMOXICLAV 625MG (TAB)
11/16/2024
11/22/2024
24
625 Mg Tab
BID
PROM X 30 Hrs, Second Degree Perineal Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes